arch43

EN_01454174_1617

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

caption

This picture taken on November 18, 2020 shows a bottle reading "Vaccine Covid-19" next to the Moderna biotech company logo. - The CEO of Moderna warned European countries on November 17 that dragging out negotiations to purchase its promising new Covid-19 vaccine will slow down deliveries, as other nations that have signed deals will get priority. The biotech company Pfizer said the day after that a completed study of its experimental Covid-19 vaccine showed it is 95 percent effective, after Moderna said its own vaccine was 94.5 percent effective, according to a preliminary analysis. (Photo by JOEL SAGET / AFP)

headline arch43

created date 2020-11-18

credit JOEL SAGET/AFP/East News

source AFP

byline JOEL SAGET

original transmission reference AFP_8VF9BN

weight 2,69MB

size 46cm x 31cm by 300dpi

keywords - Show

17, 18, 2020, 5, 94, 95, A, ACCORDING, AFTER, ANALYSIS, AS, BIOTECH, BOTTLE, BY, CEO, COMPANY, COMPLETED, COUNTRIES, COVID-19, DAY, DEALS, DELIVERIES, DOWN, DRAGGING, EFFECTIVE, EUROPEAN, EXPERIMENTAL, GET, HAVE, HORIZONTAL, IS, IT, ITS, JOEL, LOGO, MODERNA, NATIONS, NEGOTIATIONS, NEW, NEXT, NOVEMBER, OF, ON, OTHER, OUT, OWN, PERCENT, PFIZER, PHOTOGRAPHY, PICTURE, PRELIMINARY, PRIORITY, PROMISING, PURCHASE, READING, SAGET, SAID, SHOWED, SHOWS, SIGNED, SLOW, STUDIO, STUDY, TAKEN, THAT, THE, THIS, TO, VACCINE, WARNED, WAS, WILL,